These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20557836)

  • 21. Overview.
    Prudhomme M
    Anticancer Agents Med Chem; 2017; 17(1):2. PubMed ID: 28143383
    [No Abstract]   [Full Text] [Related]  

  • 22. Anticancer drug development: moving away from the old habits.
    Ades F; Zardavas D; Aftimos P; Awada A
    Curr Opin Oncol; 2014 May; 26(3):334-9. PubMed ID: 24614094
    [No Abstract]   [Full Text] [Related]  

  • 23. The changing landscape of cancer drug discovery: a challenge to the medicinal chemist of tomorrow.
    Pors K; Goldberg FW; Leamon CP; Rigby AC; Snyder SA; Falconer RA
    Drug Discov Today; 2009 Nov; 14(21-22):1045-50. PubMed ID: 19638319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. American Society of Clinical Oncology--44th Annual Meeting. Target identification and data from preclinical and clinical studies.
    Kibble A
    IDrugs; 2008 Aug; 11(8):541-4. PubMed ID: 18683082
    [No Abstract]   [Full Text] [Related]  

  • 25. From Composition to Cure: A Systems Engineering Approach to Anticancer Drug Carriers.
    MacEwan SR; Chilkoti A
    Angew Chem Int Ed Engl; 2017 Jun; 56(24):6712-6733. PubMed ID: 28028871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting cancer with hyaluronic acid-based nanocarriers: recent advances and translational perspectives.
    Cadete A; Alonso MJ
    Nanomedicine (Lond); 2016 Sep; 11(17):2341-57. PubMed ID: 27526874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in Anticancer Drug Discovery.
    Reynisson J
    Molecules; 2021 Mar; 26(7):. PubMed ID: 33804936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reverse Translation of US Food and Drug Administration Reviews of Oncology New Molecular Entities Approved in 2011-2017: Lessons Learned for Anticancer Drug Development.
    Faucette S; Wagh S; Trivedi A; Venkatakrishnan K; Gupta N
    Clin Transl Sci; 2018 Mar; 11(2):123-146. PubMed ID: 29266809
    [No Abstract]   [Full Text] [Related]  

  • 29. Preface: insights into an unsolved problem in drug delivery.
    Bergstrom DE; Wei A
    J Control Release; 2012 Dec; 164(2):107. PubMed ID: 23046619
    [No Abstract]   [Full Text] [Related]  

  • 30. Oral delivery of anticancer drugs III: formulation using drug delivery systems.
    Mazzaferro S; Bouchemal K; Ponchel G
    Drug Discov Today; 2013 Jan; 18(1-2):99-104. PubMed ID: 22981667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abstracts of the 5th International Symposium on Targeted Anticancer Therapies, 8-10 March 2007, Amsterdam, The Netherlands.
    Ann Oncol; 2007 May; 18 Suppl 4():iv17-50. PubMed ID: 17915341
    [No Abstract]   [Full Text] [Related]  

  • 32. TAT 2006. Abstracts of the 4th International Symposium on Targeted Anticancer Therapies, 16-18 March, 2006, Amsterdam, The Netherlands.
    Ann Oncol; 2006; 17 Suppl 3():iii17-52. PubMed ID: 16684793
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug Discovery and Development of Innovative Therapeutics--IBC's 13th Annual World Congress. Approaches to cancer therapy.
    Napper A
    IDrugs; 2008 Oct; 11(10):705-9. PubMed ID: 18828066
    [No Abstract]   [Full Text] [Related]  

  • 34. Newly developed strategies for multifunctional mitochondria-targeted agents in cancer therapy.
    Zhang E; Zhang C; Su Y; Cheng T; Shi C
    Drug Discov Today; 2011 Feb; 16(3-4):140-6. PubMed ID: 21182981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral delivery of anticancer drugs I: general considerations.
    Mazzaferro S; Bouchemal K; Ponchel G
    Drug Discov Today; 2013 Jan; 18(1-2):25-34. PubMed ID: 22951365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does the targeted delivery of theranostic carbon nanotubes have potential as a valid anticancer strategy?
    Das M
    Ther Deliv; 2014 Jan; 5(1):1-5. PubMed ID: 24341809
    [No Abstract]   [Full Text] [Related]  

  • 37. American Association for Cancer Research--100th Annual Meeting. New therapeutic developments: part 2. 18-22 April 2009, Denver, CO, USA.
    Gale S; McGee V; Lee W
    IDrugs; 2009 Jun; 12(6):335-8. PubMed ID: 19517309
    [No Abstract]   [Full Text] [Related]  

  • 38. Targeted drug delivery in oncology: where drug discovery meets physics.
    Hooker BA; Blomme EA
    Vet J; 2015 Aug; 205(2):120-1. PubMed ID: 26021890
    [No Abstract]   [Full Text] [Related]  

  • 39. Anticancer drug R&D landscape in China.
    Zhao S; Zhao H; Lv C; Gong J; Zhang J; Fang W; Li J; Hu X; Ba Y; Xu B; Zhang Y; Fan Y; Li K; Chen X; Yang Z; Shen L; Zhang L
    J Hematol Oncol; 2020 May; 13(1):51. PubMed ID: 32404176
    [No Abstract]   [Full Text] [Related]  

  • 40. Targeted search for anticancer drugs--CNIO cancer conference. 16-18 March, Madrid, Spain.
    Lacal JC; Carnero A
    IDrugs; 2003 May; 6(5):437-41. PubMed ID: 12841206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.